why choose us

Clinical Trials Search

Showing 16,110 of 132,656 result(s)
Assessment of Urinary Uromodulin and the Corresponding Urinary Exosomal UMOD mRNA Gene Expression as a Potential Biomarker of Diabetic Nephropathy

Status: Completed

Condition: Diabetic Nephropathy, Urinary Uromodulin, Exosomal UMOD mRNA Gene Expression

Interventions: Diagnostic Test: ACR, fasting, postprandial blood glucose ,HbA1c, creatinine, cystatin-C, BUN, Na, K , lipid profile
Use the ACR to divide diabet

Date: 2023-01-13

Aerosolized Versus Intravenous Colistin-based Antimicrobial Regimens in Hospitalized COVID-19 Patients With Bacterial Coinfection: A Randomized Controlled Trial

Status: Completed

Condition: Secondary Bacterial Infection in COVID-19 Patients

Interventions: Interventional

Date: 2023-01-13

Amplitude Titration to Improve ECT Clinical Outcomes

Status: Completed

Condition: Depression

Interventions: Device permits individualized amplitudes

Date: 2023-01-13

Evaluation of Lasofoxifene Combined With Abemaciclib Compared With Fulvestrant Combined With Abemaciclib in Locally Advanced or Metastatic ER+;HER2- Breast Cancer With an ESR1 Mutation

Status: Completed

Condition: Metastatic Breast Cancer

Interventions: 5 mg;d of oral lasofoxifene plus oral abemaciclib 150 mg twice a day

Date: 2023-01-13

Identifying Markers of Exercise Training in Heart Failure

Status: NOT_YET_RECRUITING

Condition: Heart Failure

Interventions: 12 week program of standard clinical cardiac rehabilitation for patients with symptomatic heart failure.
Patients undergo 3-times weekly sessions

Date: 2023-01-13

Phase 3 Efficacy and Durability of Ampreloxetine for the Treatment of Symptomatic nOH in Participants With Multiple System Atrophy

Status: Completed

Condition: Symptomatic Neurogenic Orthostatic Hypotension

Interventions: Oral tablet, QD

Date: 2023-01-13

A Study Evaluating the Effects of GLPG3667 Given as Oral Treatment for up to 24 Weeks in Adults With Dermatomyositis

Status: Completed

Condition: Dermatomyositis

Interventions: GLPG3667 capsules will be administered per dose and schedule specified in the arm description.

Date: 2023-01-13

STEPS Implementation Trial

Status: Completed

Condition: Autism Spectrum Disorder

Interventions: behavioral counseling

Date: 2023-01-13

Selective Lipopolysaccharide Hemosorption in Maternal Sepsis

Status: COMPLETED

Condition: Maternal sepsIs

Interventions: Hemoperfusion using continuous extracorporeal LPS adsorption with Efferon LPS therapeutic device during a period of 12h immediately following admissio

Date: 2023-01-13

Predicting Peanut Anaphylaxis and Reducing Epinephrine

Status: COMPLETED

Condition: Anaphylaxis Food

Interventions: The oral food challenge will be done as usual, and participants will wear the TEWL monitor.
The research food allergy nurse and doctor will also

Date: 2023-01-13